Article

An attempt to improve the results of treatment for breast cancer complicated by lysis

G. A. KhakimovTashkent City Oncology Dispensary, Uzbekistan Tashkent Pediatric Medical Institute, UzbekistanA. K. MadalimovTashkent City Oncology Dispensary, Uzbekistan Tashkent Pediatric Medical Institute, UzbekistanSh. G. KhakimovaTashkent City Oncology Dispensary, Uzbekistan Tashkent Pediatric Medical Institute, UzbekistanKh.I. Dzhumaniyozov DzhumaniyozovTashkent City Oncology Dispensary, Uzbekistan Tashkent Pediatric Medical Institute, Uzbekistan

DOAJ (DOAJ: Directory of Open Access Journals)repository2014en

ABI

Abstract

Lysis in locally advanced breast cancer (BC) is not a sign of tumor process dissemination. The correct elaboration of management tactics for such patients may achieve rather good early and late results. The doxorubicin + xeloda regimen for BC complicated by lysis has some advantage over the FAC regimen, without additionally increasing the rate of adverse reactions and worsening the quality of life.

Topics

Cancer Treatment and Pharmacology Chemotherapy-related skin toxicity Neutropenia and Cancer Infections

Identifiers

DOI: 10.17650/1994-4098-2014-0-3-20-24

Citations and references

Cited by 00 references

Metrics — AkademScholar · Coming soon